MTM1 and hereditary disease: With these remarks, our pioneer proof of concept of allele‐specific silencing for the most frequent DNM2 mutation responsible for AD‐CNM allows us to envision a treatment for this neuromuscular disorder and paves the way for the other CNM mutations as well as the other DNM2‐linked inherited diseases.